Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Digital Health|February 2, 2026
Enhancing early prediction of pathological complete response in breast cancer using attention-based convolutional neural networks in digital pathologyMaria Colomba Comes, Andrea Lupo, Arianna Bozzi, et al.
Scientific Reports|November 23, 2023
Comparison between vision transformers and convolutional neural networks to predict non-small lung cancer recurrenceAnnarita Fanizzi, Federico Fadda, Maria Colomba Comes, et al.
Journal of Clinical Medicine|March 27, 2025
Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic ScoreFatih Kus, Deniz Can Guven, Hasan Cagri Yildirim, et al.
Immunotherapy|June 27, 2025
Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Yakup Ozbay, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 11, 2021
Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?Oktay Halit Aktepe, Fadime Sinem Ardic, Deniz Yuce, et al.
Expert Review of Clinical Pharmacology|November 13, 2025
Immunotherapy in biliary tract cancer: effective but not enough?Alessandro Rizzo, Enes Erul, Deniz Can Guven, et al.
Northern Clinics of Istanbul|August 21, 2025
Rheumatic diseases presenting with young ischemic stroke: Revelations from tertiary center experienceHatice Ecem Konak, Serdar Can Guven, Ebru Atalar, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 12, 2021
Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapyDeniz Can Guven, Melek Seren Aksun, Taha Koray Sahin, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) StudyZiya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638Ziya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Pageof 16